Related Experiment Video
Updated: Jul 15, 2026
09:26
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Effect of a human immunodeficiency virus protease inhibitor on human monocyte function
P J Bugelski1, J M Kaplan, T K Hart
1Department of Experimental Pathology, SmithKline Beecham Pharmaceuticals, Philadelphia, PA.
AIDS Research and Human Retroviruses
|December 1, 1992
Summary
This study investigated if an HIV protease inhibitor affects human monocyte functions. The inhibitor did not impact monocyte defense mechanisms, suggesting it doesn't worsen immunosuppression in AIDS patients.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Human immunodeficiency virus (HIV) causes AIDS, relying on viral protease for maturation.
- Host cell aspartate proteases, like Cathepsins D and E, are crucial for macrophage function.
- Concerns exist that HIV protease inhibitors might exacerbate immunosuppression by affecting host proteases.
Purpose of the Study:
- To evaluate the impact of SK&F 107461, an HIV protease inhibitor, on human monocyte host defense functions.
- To determine if SK&F 107461 affects monocyte functions at concentrations inhibiting HIV replication.
Main Methods:
- In vitro inhibition assays of partially purified Cathepsin D.
- Cell-based assays measuring hemoglobin degradation, antigen processing, IL-1 beta secretion, and candidacidal activity.
- Comparison with control inhibitors Pepstatin A and Leupeptin.
Main Results:
- SK&F 107461 partially inhibited Cathepsin D in vitro but showed no effect on monocyte functions in cell-based assays.
- Monocyte functions, including antigen processing and IL-1 beta secretion, were unaffected by SK&F 107461 at antiviral concentrations.
- Control inhibitors Leupeptin and Pepstatin A demonstrated partial inhibition of monocyte accessory cell function.
Conclusions:
- SK&F 107461 does not impair critical human monocyte host defense functions.
- The study suggests that HIV protease inhibitors like SK&F 107461 may not exacerbate immunosuppression by affecting these specific monocyte functions.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...